NASDAQ:HBIO | Free Cash Flow | HARVARD BIOSCIENCE INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$662,000.00$426,000.00-$1.09M
2025-12-31-$96,000.00$449,000.00-$545,000.00
2025-03-31$2.99M$513,000.00$2.47M
2024-12-31$1.73M$301,000.00$1.42M7911.11%
2024-03-31$1.4M$645,000.00$758,000.00
2023-12-31$4.3M$830,000.00$3.47M
2023-03-31$1.81M$224,000.00$1.59M255.31%
2022-12-31$2.68M$235,000.00$2.44M
2022-03-31-$1.99M$471,000.00-$2.46M
2021-12-31$117,000.00$358,000.00-$241,000.00-25.08%
2021-03-31$1.04M$151,000.00$886,000.00
2020-12-31$2.49M$64,000.00$2.43M
2020-03-31$2.87M$241,000.00$2.63M
2019-12-31$2.22M$438,000.00$1.78M324.00%
2019-03-31$2.01M$143,000.00$1.87M
2018-12-31$2.59M$95,000.00$2.5M87.28%
2018-03-31$448,000.00$493,000.00-$45,000.00
2017-12-31-$939,000.00$213,000.00-$1.15M-115.32%
2017-03-31-$610,000.00$198,000.00-$808,000.00
2016-12-31$1.73M
2016-03-31-$726,000.00
2015-12-31$1.76M
2015-03-31-$497,000.00
2014-12-31$1.26M
2014-03-31$1.07M
2013-12-31$1.25M
2013-03-31$576,000.00
2012-12-31$1.41M
2012-03-31$1.61M
2011-12-31$2.64M
2011-03-31$1.14M
2010-12-31$4.25M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$6.73M$1.26M$5.47M
2024-12-31$1.44M$2.64M-$1.2M
2023-12-31$14.03M$1.79M$12.24M
2022-12-31$1.15M$1.59M-$438,000.00
2021-12-31$1.26M$1.2M$67,000.00
2020-12-31$9.33M$1.15M$8.18M
2019-12-31$8.05M$1.22M$6.83M
2018-12-31$2.88M$986,000.00$1.9M
2017-12-31$1.06M$890,000.00$167,000.00
2016-12-31$5.38M
2015-12-31$705,000.00
2014-12-31$4.35M
2013-12-31$4.06M
2012-12-31$8.06M
2011-12-31$6.65M
2010-12-31$12.29M
2009-12-31$16.51M